Old North State Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3M Buy
124,354
+5,140
+4% +$134K 1.28% 31
2026
Q1
$3.35M Buy
119,214
+8,413
+8% +$224K 1.55% 27
2025
Q4
$2.76M Buy
110,801
+9,222
+9% +$233K 1.3% 31
2025
Q3
$2.59M Buy
101,579
+859
+0.9% +$21.2K 1.21% 31
2025
Q2
$2.44M Buy
100,720
+12,467
+14% +$291K 1.27% 29
2025
Q1
$2.24M Buy
88,253
+8,812
+11% +$231K 1.25% 30
2024
Q4
$2.11M Buy
79,441
+15,194
+24% +$412K 1.19% 31
2024
Q3
$1.86M Buy
64,247
+8,235
+15% +$240K 1.04% 34
2024
Q2
$1.57M Buy
56,012
+4,812
+9% +$132K 1.03% 35
2024
Q1
$1.42M Buy
+51,200
New +$1.42M 0.93% 36

Other funds holding PFE

Old North State Wealth Management's PFE Position: Q2 2026 in Review

Old North State Wealth Management increased its Pfizer (PFE) stake by 4.3% in Q2 2026, buying an estimated $134K and bringing the position to 124,354 shares worth $3M. The position accounts for 1.28% of the portfolio, ranked #31.

Old North State Wealth Management first reported a position in PFE in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.35M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Old North State Wealth Management held 124,354 shares of Pfizer worth $3M as of Q2 2026.
  • Old North State Wealth Management bought 5,140 Pfizer shares in Q2 2026, an estimated $134K.
  • Pfizer made up 1.28% of Old North State Wealth Management's portfolio in Q2 2026, its #31 holding.
  • Old North State Wealth Management first reported a position in Pfizer in Q1 2024 and has held it in 10 quarters since.
  • Old North State Wealth Management's Pfizer position peaked at $3.35M in Q1 2026.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Old North State Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.